Close Menu

tamoxifen

Two new studies show that patients with advanced HR-positive, HER2-negative breast cancer had higher survival when they received combination therapies.

Such prognostic information could aid clinicians in making decisions about radiotherapy for postmenopausal women with breast cancer.